The effectiveness of daclatasvir based therapy in European patients with chronic hepatitis C and advanced liver disease
Young J, Weis N, Hofer H, Irving W, Weiland O, Giostra E, Pascasio JM, Castells L, Prieto M, Postema R, Lefevre C, Evans D, Bucher HC, Calleja JL.
BMC Infect Dis. 2017;17(1):45.
NIHR Acknowledged: Yes
|Professor Will Irving||Clinical virology, especially in relation to viral hepatitis and the human herpes viruses. This encompasses diagnosis, management and pathogenesis of disease.|